Visit | 1 | 2 | 3–4a | 5 | 6 | 7–12 |
---|---|---|---|---|---|---|
Time point | Screening | Day of surgery, pathology | POD 5 POD 10–12 | Day of discharge | POD 90 | POM 6, 12, 18, 24, 30, 36 (or pre-mature trial termination) |
Type of visit | Inpatient | Inpatient | Inpatient | Inpatient | Outpatient (inpatient) (telephone) | Outpatient (telephone) |
Written informed consent | X | |||||
Preoperative inclusion/exclusion criteria | X | |||||
Intraoperative inclusion criteria | X | |||||
Demographics and baseline data | X | |||||
Medical history | X | |||||
Surgery data | X | |||||
Randomisation | X | |||||
Primary endpoint | ||||||
Disease-free survival | X | X | X | X | ||
Secondary endpoints | ||||||
Pathologic data | X | |||||
Postoperative morbidity | X | X | X | |||
Length of hospital stay | X | |||||
Overall survival | X | X | X | X | ||
Local recurrence | X | X | X | X | ||
Patient-reported outcomes (PRO) | ||||||
Quality of recoveryc | X | (X)d | ||||
Quality of life assessmentb | X | X | X | |||
Safety | ||||||
SAE | X | X | X | X | X |